PATENT CLAIM ANALYSIS

Application Number: 15741996
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting DGAT2 expression, which may be useful for treating, preventing, or ameliorating a disease associated with DGAT2.

Claim (Index 25):
The compound of  claim 20 , wherein the modified nucleobase is a 5-methylcytosine.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14050574', '14854281', '13660885', '13623337', '14959714']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8154172333331929
- 35 USC 102 Novelty (BERT): 0.5241788984904272
- Combined Prediction Score: 0.7862933998489163
- Mean Citation Score: 336.2592820000001
- Max Citation Score: 342.58948
- Similarity Product: 290.152462217412

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test